Sodium thiosulfate not always resolves calciphylaxis: An ambiguous response

Renal Failure

Volumn 33, Issue 1, 2011, Pages 84-87

  Miceli, Salvatore ^a   Milio, Glauco ^a   Placa, Sergio La ^a   Raimondo, Domenico Di ^a   Tuttolomondo, Antonino ^a   Vecchi, Maurizio Li ^a   Licata, Giuseppe ^a   Pinto, Antonio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Calcific uremic arteriolopathy; Calciphylaxis; Thiosulfate

Indexed keywords

SODIUM THIOSULFATE;

ADULT; ANAMNESIS; ARTICLE; CALCINOSIS; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY TEST; PRIORITY JOURNAL; SKIN BIOPSY; TREATMENT RESPONSE;

ANTIOXIDANTS; CALCIPHYLAXIS; CHELATING AGENTS; FATAL OUTCOME; FEMALE; HUMANS; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; THIOSULFATES; TREATMENT OUTCOME;

EID: 78651320527     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.536288     Document Type: Article

References (14)

1. Budisavljevic MN, Cheek D, Ploth DW. Calciphylaxis in Chronic renal failure. J Am Soc Nephrol. 1996;7:978-982.
2. Wang HY, Yu CC, Huang CC. Successful treatment of severe calciphylaxis in a hemodialysis patient using low-calcium dialysate and medical parathyroidectomy: Case report and literature review. Ren Fail. 2004;26:77-82.
3. Wilmer WA, Magro CM. Calciphylaxis: Emerging concepts in prevention and treatment. Semin Dial. 2002;15: 172-186.
4. Hayden MR, Tyagi SC, Kolb L, Sowers LR, Khanna R. Vascular ossification-calcification in methabolic syndrome, type 2 diabetes mellitus, chronic Kidney disease, and calciphylaxis-calcific ure-mic arteriolopathy: the emerging role of sodium thiosulfate. Car-diovasc Diabetol. 2005;4:4.
5. Mazhar AR, Johnson RJ, Gillen D, et al. Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int. 2001;60:324-332.
6. Hayden MR, Goldsmith D, Sowers JR, Khanna R. Calciphy-laxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate. Int Urol Nephrol. 2008;40:443-451.
7. Pasch A, Schaffner T, Huynh-Do U, Frey BM, Frey FJ, Farese S. Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int. 2008;74:1376-1378.
8. Rogers NM, Coates PT. Calcific uraemic arteriolopathy: An update. Curr Opin Nephrol Hypertens. 2008;17:629-634.
9. Lipsker D, Chosidow O, Martinez F. Low-calcium dialysis in calciphylaxis. Arch Dermatol. 1997;133:798-789.
10. Yatzidis H. Successful sodium thiosulphate treatment for recurrent calcium urolithiasis. Clin Nephrol. 1985;23:63-67.
11. Brucculeri M, Cheig J, Bauer G, Serur D. Long term intrave nous Thiosulphate in the treatment of a patient with calciphy-laxis. Semin Dial. 2005;18:431-434.
12. Subramanian K, Wallace H, Sinniah R, Saker B. Complete resolution of recurrent calciphylaxis with long-term intravenous sodium thiosulphate. Australas J Dermatol. 2008;49:30-34.
13. Guerra G, Shah RC, Ross EA. Rapid resolution of calciphylaxis with intravenous sodium thiosulphate and continuous veno-venous haemofiltration using low calcium replacement fluid: case report. Nephrol Dial Transplant. 2005;20:1260-1262.
14. Cicone JS, Petronis JB, Embert CD, Spector DA. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis. 2004;43:1104-1108.